Приказ основних података о документу
Supplementary material to: "Ph-responsive release of ruthenium metallotherapeutics from mesoporous silica-based nanocarriers"
dc.creator | Mladenović, Minja | |
dc.creator | Morgan, Ibrahim | |
dc.creator | Ilić, Nebojša | |
dc.creator | Saoud, Mohamad | |
dc.creator | Pergal, Marija | |
dc.creator | Kaluđerović, Goran N. | |
dc.creator | Knežević, Nikola Ž. | |
dc.date.accessioned | 2021-05-07T21:26:08Z | |
dc.date.available | 2021-05-07T21:26:08Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://cer.ihtm.bg.ac.rs/handle/123456789/4573 | |
dc.description.abstract | Figure S1. Full range FTIR spectra of the synthesized materials. Figure S2. Particle size distribution of Ru-modified nanoparticles in water (top) and culture medium (bottom). Figure S3. EDS chromatograms of (a) MSN-H1[Ru]; (b) MSN-H2[Ru] and (c) MSN[Ru] with insets representing Ru mapping. Figure S4. UV/VIS spectra of supernatants at different pH values after 48 h of stirring. Figure S5. Viability of the B16F1 cells determined with CV and MTT assays treated (48 h) with pristine MSN on pH 5.0 and 7.2. | sr |
dc.language.iso | en | sr |
dc.publisher | MDPI | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200358/RS// | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200026/RS// | sr |
dc.relation | The European Union’s Horizon 2020 research and innovation programme under grant agreement 952259 (NANOFACTS) | sr |
dc.relation | The German Academic Exchange Service (DAAD) [grant number: 57393212] | sr |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/739570/EU// | sr |
dc.relation.isreferencedby | https://doi.org/10.3390/pharmaceutics13040460 | |
dc.rights | openAccess | sr |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Pharmaceutics | sr |
dc.subject | Cancer treatment | sr |
dc.subject | Controlled drug delivery | sr |
dc.subject | Mesoporous silica nanoparticles | sr |
dc.subject | PH-responsive drug delivery | sr |
dc.subject | Ruthenium-based anti-cancer drugs | sr |
dc.title | Supplementary material to: "Ph-responsive release of ruthenium metallotherapeutics from mesoporous silica-based nanocarriers" | sr |
dc.type | dataset | sr |
dc.rights.license | BY | sr |
dcterms.abstract | Младеновић, Миња; Илић, Небојша; Саоуд, Мохамад; Пергал, Марија; Калуђеровић, Горан Н.; Кнежевић, Никола Ж.; Морган, Ибрахим; | |
dc.description.other | The supplementary material for: Mladenović, M., Morgan, I., Ilić, N., Saoud, M., Pergal, M. V., Kaluđerović, G. N.,& Knežević, N. (2021). Ph-responsive release of ruthenium metallotherapeutics from mesoporous silica-based nanocarriers. Pharmaceutics, MDPI, 13(4), 460. [https://doi.org/10.3390/pharmaceutics13040460] | |
dc.description.other | Published version of the article: [https://cer.ihtm.bg.ac.rs/handle/123456789/4572] | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_cer_4573 | |
dc.identifier.fulltext | https://cer.ihtm.bg.ac.rs/bitstream/id/20226/pharmaceutics-13-00460-s001.pdf | |
dc.type.version | publishedVersion | sr |